Brevan Howard Capital Management’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$689K Sell
14,456
-5,310
-27% -$246K 0.01% 1269
2026
Q1
$866K Sell
19,766
-39,723
-67% -$1.81M 0.01% 985
2025
Q4
$2.64M Sell
59,489
-6,132
-9% -$264K 0.03% 393
2025
Q3
$2.77M Buy
65,621
+40,037
+156% +$1.61M 0.01% 432
2025
Q2
$938K Buy
+25,584
New +$950K 0.01% 1097
2024
Q1
– Sell
-12,161
Closed -$373K – 1253
2023
Q4
$373K Buy
+12,161
New +$390K ﹤0.01% 621

Other funds holding OHI

Brevan Howard Capital Management's OHI Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Omega Healthcare (OHI) stake by 27% in Q2 2026, selling an estimated $246K and leaving 14,456 shares worth $689K. The position accounts for 0.01% of the portfolio, ranked #1269.

Brevan Howard Capital Management first reported a position in OHI in Q4 2023 and has held it in 6 quarters since. The position peaked at $2.77M in Q3 2025. 764 funds tracked by Wall St. Rank hold OHI as of Q2 2026.

  • Brevan Howard Capital Management held 14,456 shares of Omega Healthcare worth $689K as of Q2 2026.
  • Brevan Howard Capital Management sold 5,310 Omega Healthcare shares in Q2 2026, an estimated $246K.
  • Omega Healthcare made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #1269 holding.
  • Brevan Howard Capital Management first reported a position in Omega Healthcare in Q4 2023 and has held it in 6 quarters since.
  • Brevan Howard Capital Management's Omega Healthcare position peaked at $2.77M in Q3 2025.
  • 764 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.